COPD: Clinical phenotypes

Pulmonary Pharmacology and Therapeutics

Volumn 15, Issue 4, 2002, Pages 341-351

  Petty, Thomas L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Asthma; Asthmatic bronchitis; Chronic bronchitis; Clinical phenotypes; COPD; Emphysema

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DILTIAZEM; DIURETIC AGENT; IMMUNOMODULATING AGENT; MONOCLONAL ANTIBODY; SALBUTAMOL; THEOPHYLLINE;

ALPHA ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EMPHYSEMA; EXPIRATORY RESERVE VOLUME; HISTOPATHOLOGY; HUMAN; INSPIRATORY RESERVE VOLUME; LUNG FUNCTION TEST; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SPIROMETRY;

EID: 0036382865     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2002.0380     Document Type: Article

References (39)

1. Petty T L, Miercort R, Ryan S et al. The functional and bronchographic evaluation of postmortem human lungs. Am Rev Respir Dis 1965; 92: 450-458.
2. Silvers G W, Maisel J C, Petty T L et al. Central airway resistance in excised emphysematous lungs. Chest 1972; 61: 603-612.
3. Silvers G W, Maisel J C, Petty T L et al. Flow limitation during forced expiration in excised human lungs. J Appl Physiol 1974; 36: 737-744.
4. Silvers G W, Petty T L, Stanford R E et al. The elastic properties of lobes of excised human lungs. Am Rev Respir Dis 1979; 120: 207-209.
5. Petty T L, Silvers G W, Stanford R E. Small airway disease is associated with elastic recoil changes in excised human lungs. Am Rev Respir Dis 1984; 130: 42-45.
6. Petty T L, Silvers G W, Stanford R E. Radial traction and small airways disease in excised human lungs. Am Rev Respir Dis 1986; 133: 132-135.
7. Silvers G W, Petty T L, Stanford R E. Elastic recoil changes in early emphysema. Thorax 1980; 35: 490-495.
8. Petty T L, Silvers G W, Stanford R E et al. Small airway pathology is related to increased closing capacity and abnormal slope of phase III in excised human lungs. Am Rev Respir Dis 1980; 121: 449-456.
9. Petty T L, Silvers G W, Stanford R E. Mild emphysema is associated with reduced elastic recoil and increased lung size but not with airflow limitation. Am Rev Respir Dis 1987; 136: 867-871.
10. Petty T L, Nett L M, Finigan M M et al. A comprehensive care program for chronic airway obstruction. Methods and preliminary evaluation of symptomatic and functional improvement. Ann Intern Med 1969; 70: 1109-1120.
11. Petty T L, Brink G A, Miller M W et al. Objective functional improvement in chronic airway obstruction. Chest 1970; 57: 216-223.
12. Petty T L, Finigan M M. Clinical evaluation of prolonged ambulatory oxygen therapy in chronic airway obstruction. Am J Med 1968; 45: 242-252.
13. Petty T L, Neff T A, Creagh C E et al. Outpatient oxygen therapy in chronic obstructive pulmonary disease. A review of 13 years' experience and an evaluation of modes of therapy. Arch Intern Med 1979; 139: 28-32.
14. Petty T L (Chairman). Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Int Med 1980; 93: 391-398.
15. Thurlbeck W M. Pathophysiology: Clinic pathologic correlations. In: Thurlbeck W M ed. Chronic obstructive lung disease, ch. 9. WB Saunders, Philadelphia 1976, p 456.
16. Dornhorst A C. Respiratory insufficiency (Frederick Price Memorial Lecture). Lancet 1955; 1: 1185-1187.
17. Reid L. Measurement of the bronchial moucous gland layer: a diagnostic yardstick in chronic bronchitis.
18. Mitchell R S, Ryan S F, Petty T L et al. The significance of morphologic chronic hyperplastic bronchitis. Am Rev Respir Dis 1966; 93: 720-729.
19. Niewoehner D E, Erbland M L, Deupree R H et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999; 340: 1941-1947.
20. van den Boom G, Ratten-van Molken M P, Molema J et al. The cost effectiveness of early treatment with fluticasone propionate 250 mg twice a day in subjects with obstructive airway disease. Results of the DIMCA program. Am J Respir Crit Care Med 2001; 164: 2057-2066.
21. Mountain R C, Zwillich C W, Weil J V. Hypoventilation in obstructive lung disease. The role of familial factors. N Engl J Med 1978; 298: 521-525.
22. Shapiro S D. The pathogenesis of emphysema: the elastase: antielastase hypothesis 30 years later. Proc Assoc of Am Physicians 1995; 107: 346-352.
23. Silverman E K, Pierce J A, Province M D et al. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. Ann Intern Med 1989; 111: 982-991.
24. Gaillard M C, Kilroe-Smith T A, Noqueira C et al. Alpha-1-protease inhibitor in bronchial asthma: phenotypes and biochemical characteristics. Am Rev Respir Dis 1992; 145: 1311-1315.
25. Dunand P, Cropp G A, Middleton E Jr: Clinical conference: severe obstructive lung disease in a 14 year old girl with alpha-1-antitripsin deficiency. J Allergy Clin Immunol 1976; 57: 615-622.
26. Mannino D M, Gagnon R C, Petty T L et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689.
27. 1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
28. Tashkin D P, Altose M D, Connett J E et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung health Study Research Group. Am J Respir Crit Care Med 1996; 153: 1802-1811.
29. Guyatt G H, Townsend M, Nogradi S et al. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med 1988; 148: 1949-1952.
30. Burrows B, Bloom J W, Traver G A et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317: 1309-1314.
31. Petty T L, Silvers G W, Stanford R E. Mild emphysema is associated with reduced elastic recoil and increased lung size, but not with airflow limitation. Am Rev Respir Dis 1987; 136: 867-871.
32. Burrows B, Knudson R J, Camilli A E et al. The 'horse racing effect' and predicting the decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis 1987; 135: 788-793.
33. Peto R, Speizer F E, Cochrane A L et al. The relevance in adults of airflow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983; 128: 491-500.
34. Tager I B, Segal M R, Munoz A et al. The effect of maternal cigarette smoking on the pulmonary function of children and adolescents. Analyses of data from two populations. Am Rev Respir Dis 1987; 136: 1366-1370.
35. Petty T L, Weinmann G G. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. JAMA 1997; 277: 246-253.
36. Pauwels R A, Buist S A, Calverley G et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respit Crit care Med 2001; 163: 1256-1276.
37. Ferguson G T, Enright P L, Buist S et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000; 117: 1148-1161.
38. Barnes P J. Chronic Obstructive Pulmonary Disease. N Engl J Med 2000; 343: 269-280.
39. Brown P J, Greville H W, Finucane K E. Asthma and irreversible airflow obstruction. Thorax 1984; 39: 131-136.